Indicated Prevention With At-Risk Gamblers - Full Text View

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00078273

Purpose

The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.

Condition	Intervention	Phase
Gambling	Behavioral: Brief Personal Feedback Intervention	Phase II

MedlinePlus related topics: Compulsive Gambling

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Indicated Prevention With At-Risk Gamblers

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	225
Study Start Date:	July 2003
Estimated Study Completion Date:	June 2006

Detailed Description:

Participants in this study will be randomly assigned to a personal feedback intervention (PFI) or assessment only for 3 years. The PFI intervention will be delivered in a single session. Measures will include the NORC DSM Screen for Problem Gambling (NODS), the South Oaks Gambling Screen (SOGS), Gambling Quantity and Perceived Norms, Perceived Injunctive Gambling Norms, Gambling Problems Index, gambling frequency, attitudes and beliefs about gambling and self-control, readiness to change, gambling expectancies, gambling motives, gambling risk perception, psychiatric symptoms, assertiveness, coping skills, substance use, alcohol-related problems, self-determination, and social desirability.

Eligibility

Ages Eligible for Study:	17 Years to 24 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

College student
South Oaks Gambling Screen (SOGS) score greater than 3

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00078273

Locations

United States, Washington
University of Washington; Department of Psychiatry and Behavioral Sciences
Seattle, Washington, United States, 98195

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

Study ID Numbers:	R21 MH67026, DATR A2-AII
Study First Received:	February 20, 2004
Last Updated:	September 19, 2008
ClinicalTrials.gov Identifier:	NCT00078273
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Gambling

ClinicalTrials.gov processed this record on January 16, 2009